GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (OTCPK:HLOSF) » Definitions » Short Percentage of Float

HLOSF (Healios KK) Short Percentage of Float


View and export this data going back to 2020. Start your Free Trial

What is Healios KK Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Healios KK's Short Percentage of Float

For the Biotechnology subindustry, Healios KK's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healios KK's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Healios KK's Short Percentage of Float falls into.


;
;

Healios KK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (OTCPK:HLOSF) » Definitions » Short Percentage of Float
Comparable Companies
TSE:7774 TSE:4563 TSE:7776 TSE:4599 TSE:4575 TSE:219A TSE:190A TSE:4978 TSE:4588 TSE:7096 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
4593:Japan 6VX:Germany
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Website
https://www.healios.co.jp
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.